Avant Diagnostics

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics to Present at Upcoming Investor Conferences https://t.co/PR7gpMRbwx $AVDX

[Avant Diagnostics @AvantAVDX]

$AVDX to present Sunday June 5, 8:00-11:30 AM & Monday June 6, 1:00-4:30 PM CT at #ASCO16. https://t.co/F7ooffj3nH

[Avant Diagnostics @AvantAVDX]

$AVDX announced acceptance of two poster presentations at @ASCO Annual Meeting June 3-7. Details here: https://t.co/F7ooffj3nH

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health... https://t.co/tjAmrEDjzQ

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health https://t.co/mC9Dp4EdG7 $AVDX

[Avant Diagnostics @AvantAVDX]

$AVDX Aims to Cut Costs and Deliver Fast Results with Ovarian Cancer Detection Test https://t.co/KuVP3FxS47 https://t.co/N118BWYkOl

[Avant Diagnostics @AvantAVDX]

$AVDX Participating in the ‘War on Cancer’ With Preventative Early Detection Technology https://t.co/Tcst8cag8q https://t.co/g3Adzo4t2v

[Avant Diagnostics @AvantAVDX]

$AVDX Presenting at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference... https://t.co/T1PpMSBvdD

[Avant Diagnostics @AvantAVDX]

$AVDX Announces a Partnership of Promise with Amarantus Diagnostics https://t.co/E7cLXfAAUD https://t.co/fg7s5iwcwk

[Avant Diagnostics @AvantAVDX]

$AVDX Early Detection of Ovarian Cancer Increases Survival Rates by Five Times https://t.co/vgVI5y6q7f https://t.co/rckWcj9IeO

[Avant Diagnostics @AvantAVDX]

$AVDX Positioned to Expand Clinical Pipeline following Entry into Letter of Intent to Merge with Amarantus... https://t.co/uf6FOZOiIa

[Avant Diagnostics @AvantAVDX]

$AVDX Battling Ovarian Cancer with Its Early Detection OvaDx Test https://t.co/SiIyhKjx1a https://t.co/mRVonSo0zt

[Avant Diagnostics @AvantAVDX]

$AVDX Trials and Tribulations https://t.co/C0l6EcmLMT https://t.co/rJPVdQhrQd

[Avant Diagnostics @AvantAVDX]

$AVDX Ovarian Cancer Early Detection Diagnostic Tech Bolstered Mightily By Amarantus Bioscience Merger... https://t.co/XwWhEDgfv2

[Avant Diagnostics @AvantAVDX]

$AVDX Announces Letter of Intent to Merge with Diagnostics Division of Amarantus Bioscience Holdings, Inc.... https://t.co/WPW0tzkBp3

[Avant Diagnostics @AvantAVDX]

$AVDX Set to Exploit New Opportunities in the Laboratory Testing Market https://t.co/AKRppACxEA https://t.co/87ArGzCT5Z

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics, Inc. (AVDX) Developing the Future of Ovarian Cancer Screenings https://t.co/2T30jveejj

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics, Inc. (AVDX) Aims to Provide Early Detection Solutions for Better Treatment... https://t.co/cbOnPQUhXV

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics (AVDX): An Ounce of Prevention is Worth a Pound of Cure https://t.co/7AyIxUureb

[Avant Diagnostics @AvantAVDX]

Avant Diagnostics (ADVX) Leading an Evolution in Early Detection of Ovarian Cancer https://t.co/2UOXWr8iLU